Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(1)
Terminated(1)
Other(1)

Detailed Status

Withdrawn1
Completed1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

withdrawn133%
completed133%
unknown133%

Recent Activity

0 active trials
Showing 3 of 3
unknown

"eyeMax Insight" Cholangioscopy for Unexplained Bile Duct Stenosis

NCT05905744
withdrawn

Factors Associated With Increased Risk of Bacteremia and Cholangitis in ERCP With Cholangioscopy

NCT02543957
completednot_applicable

Prospective Evaluation of the Ability of Spyglass Cholangioscopy to Facilitate Radiation Free ERCP

NCT03074201

Clinical Trials (3)

Showing 3 of 3 trials
NCT05905744

"eyeMax Insight" Cholangioscopy for Unexplained Bile Duct Stenosis

Unknown
NCT02543957

Factors Associated With Increased Risk of Bacteremia and Cholangitis in ERCP With Cholangioscopy

Withdrawn
NCT03074201Not Applicable

Prospective Evaluation of the Ability of Spyglass Cholangioscopy to Facilitate Radiation Free ERCP

Completed

All 3 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
3